MedLife reports turnover of 1.66 billion RON, up 25 percent in the first nine months

MedLife announces the financial results for the first nine months of the year. The company recorded a turnover of 1.66 billion RON, an increase of 25.4 percent compared to the same period last year.

The main divisions of the Group that experienced significant growth during the January – September 2023 period, compared to the same period last year, are the clinics with a 36 percent increase, hospitals with a 28 percent increase, the corporate division with a 16 percent increase, and laboratories with a 12 percent increase.

Thus, at group level, the third quarter was marked by the opening of two new oncology centers in Brăila and Vâlcea under the Neolife umbrella. This expansion was accompanied by other significant investments in oncology, including the acquisition of radiotherapy equipment and the modernization of existing equipment in Brașov and Sibiu.

Additionally, the company continued to strengthen the hospital division through investments in units such as the Nord Pipera Hospital, scheduled to be inaugurated at the end of November. The new hospital will cover top-notch cardiac surgery, interventional procedures, and cardiology, with a particular focus on oncology.

In addition to developing the oncological infrastructure, MedLife has invested in state-of-the-art equipment in numerous hospitals across the country, such as Medical Park in Bucharest, Humanitas in Cluj, MedLife Hospital in Brașov, and Polisano in Sibiu, thereby enhancing medical capabilities in these units.

„The evolution of the MedLife Group reflects the continuous and sustainable growth of the financial performance and of our operational activities. Carefully evaluating the market, we observe sustained consumption of MedLife medical services, even if on the local market the growth rates are not as high as in previous years. Our strategic decision to invest in oncology and hospitals, sectors less affected by economic fluctuations, underlies our optimism that we will fully reap the rewards of our investments in the coming years. We remain steadfast in our commitment to performance and towards pacient needs, fulfilling the constant changing needs of the market,” stated Mihai Marcu, President and CEO of MedLife Group.